arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

LENSAR, Inc.

LNSR
$5.76 ▲ +0.01 (+0.26%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
8 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Neutral
auto_awesome

Analytical Summary

LENSAR, Inc. shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $68.9M
Dividend Yield
Revenue Growth 9.2%
Op. Margin -42.1%
ROIC 74.6%
FCF / Share $-1.25
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$58.44M
↑ +9.2%
Net Income Profit after all expenses
$-34.28M
↓ -9.2%
Operating Margin Operating profit as % of sales
-42.1%
↓ -111.0% 6th
FCF / Share Free cash flow per share
$-1.25
↓ -490.9%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
100
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters